Cargando…

Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters

Gepotidacin is a novel triazaacenaphthylene antibiotic in phase III development. Based on nonclinical in vitro characterization of gepotidacin metabolism, two phase I studies were conducted in healthy participants to investigate clinical drug–drug interactions (DDIs). We assessed gepotidacin as a DD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barth, Aline, Perry, Caroline R., Shabbir, Shaila, Zamek‐Gliszczynski, Maciej J., Thomas, Sebin, Dumont, Etienne F., Brimhall, Darin B., Nguyen, Dung, Srinivasan, Meenakshi, Swift, Brandon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087077/ https://www.ncbi.nlm.nih.gov/pubmed/36642822 http://dx.doi.org/10.1111/cts.13477

Ejemplares similares

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants
por: Barth, Aline, et al.
Publicado: (2022)

731. Pharmacokinetics of Gepotidacin (GSK2140944) in Subjects with Hepatic Impairment
por: Hands, Jonathan T, et al.
Publicado: (2019)

1115. Evaluation of Gepotidacin (GSK2140944) Pharmacokinetics and Food Effect in Japanese Subjects
por: Hossain, Mohammad, et al.
Publicado: (2021)

Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants
por: Barth, Aline, et al.
Publicado: (2022)

Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea
por: Scangarella-Oman, Nicole E, et al.
Publicado: (2023)

Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections
por: Scangarella-Oman, Nicole E., et al.
Publicado: (2022)

Efficacy of Human Exposures of Gepotidacin (GSK2140944) against Escherichia coli in a Rat Pyelonephritis Model
por: Hoover, Jennifer L., et al.
Publicado: (2019)

1482. Microbiological Analysis from a Phase II Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections
por: Scangarella-Oman, Nicole, et al.
Publicado: (2019)

Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
por: O'Riordan, William, et al.
Publicado: (2017)

Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)
por: Overcash, J. Scott, et al.
Publicado: (2020)

1479. Clinical Efficacy and Safety Analysis Evaluating Oral Gepotidacin (GSK2140944) from a Phase IIa Study in the Treatment of Uncomplicated Urinary Tract Infections
por: Overcash, J Scott, et al.
Publicado: (2019)

Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944)
por: Nuzzo, Andrea, et al.
Publicado: (2021)

1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections
por: Zimmerman, Eric I, et al.
Publicado: (2019)

Pharmacokinetics of Gepotidacin in Renal Impairment
por: Hossain, Mohammad, et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects
por: Tiffany, Courtney, et al.
Publicado: (2022)

Pharmacokinetics of Gepotidacin in Subjects With Normal Hepatic Function and Hepatic Impairment
por: Hossain, Mohammad, et al.
Publicado: (2021)

Cybercrime: Victimization, Perpetration, and Techniques
por: Hawdon, James
Publicado: (2021)

Epilepsy and the gut: Perpetrator or victim?
por: Al-Beltagi, Mohammed, et al.
Publicado: (2022)

A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
por: Wicha, Sebastian G., et al.
Publicado: (2017)

Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
por: Bleasby, Kelly, et al.
Publicado: (2021)

Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague
por: Nguyen, Dung, et al.
Publicado: (2021)

Comprehensive PBPK model to predict drug interaction potential of Zanubrutinib as a victim or perpetrator
por: Wang, Kun, et al.
Publicado: (2021)

Victimization and Perpetration Experiences of Adults With Autism
por: Weiss, Jonathan A., et al.
Publicado: (2018)

Intimate partner homicide: victims and the dynamics of victim – perpetrator relationship
por: Matias, Andreia, et al.
Publicado: (2021)

Bullying among adolescents: are the victims also perpetrators?
por: Reisen, Andressa, et al.
Publicado: (2019)

The importance of risk factors for bullying perpetration and victimization()()
por: Farrington, David P.
Publicado: (2020)

Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling
por: Mulford, Darcy J., et al.
Publicado: (2023)

Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944)
por: Nuzzo, Andrea, et al.
Publicado: (2021)

Victims and/or perpetrators? Towards an interdisciplinary dialogue on child soldiers
por: Derluyn, Ilse, et al.
Publicado: (2015)

Intimate partner violence victimization and perpetration as precursors to suicide
por: Kafka, Julie M., et al.
Publicado: (2022)

Perpetrators and victims of cyberbullying among youth with conduct disorder
por: Baumann, Sarah, et al.
Publicado: (2022)

Bullying victimization and perpetration: some answers and more questions()
por: Voisin, Dexter R., et al.
Publicado: (2023)

Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
por: Sanders, Maike Isabell, et al.
Publicado: (2022)

Bullying and Cyberbullying Perpetration and Victimization: Prospective Within-Person Associations
por: Camacho, Antonio, et al.
Publicado: (2022)

Stepping into Perpetrators’ Shoes: How Ingroup Transgressions and Victimization Shape Support for Retributive Justice through Perspective-Taking With Perpetrators
por: Li, Mengyao, et al.
Publicado: (2019)

Perpetrator as a Potential Victim. Does Threatened Retaliation from the Victim Reduce Obedience towards Authority?
por: Grzyb, Tomasz, et al.
Publicado: (2017)

The trafficking of women and girls in Taiwan: characteristics of victims, perpetrators, and forms of exploitation
por: Huang, Lanying
Publicado: (2017)

Disparities in Perpetrators, Locations, and Reports of Victimization for Sexual and Gender Minority Adolescents
por: Kaufman, Tessa M. L., et al.
Publicado: (2022)

Differences and Similarities between Perpetrators of Ethnic and Non-Ethnicity-Based Victimization
por: Bayram Özdemir, Sevgi, et al.
Publicado: (2020)

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
por: Capuano, Annalisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hh3nog0mqtguq23sk688fbu7mi